Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a multi-centre, phase II, open-label, 12-month clinical trial for patients previously
treated with WST09 (Tookad) who have positive prostate biopsies for cancer.
The study aims at delivering a second WST09 treatment for the purpose of eradicating the
localized prostate cancer.